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Abstract 
 
Plant with medicinal property contains different types of bioactive compounds and these compounds are effective 
against certain diseases.  Biofilm infection is a disease caused by biofilm which is associated with the respiratory and 
gastrointestinal infections. Biofilm-producing bacteria as such Pseudomonas aeruginosa strain PA14 is a serious 
treat in hospitals. The bacterium possesses many virulent factors that contributed to its pathogenesis and resistance 
thus caused the inhibition and removal of its biofilms a difficult task. This study therefore attempts to identify 
natural antibiofilm agents against the P. aeruginosa PA14 biofilms. The activity of plant extracts and subsequently 
purified compounds was evaluated using a stepwise separation process called bioassay-guided fractionation. The 
fractionation process involved the use of chromatographic techniques and compounds were identified using NMR, 
GC-MS and LC-MS. A total of four bioactive fractions namely (E333F1S1), (E341), (HA6) and (M338B) have been 
discovered with antibiofilm activity and were selected for further investigation. The active fraction from Ribes 
nigrum leaf (E333F1S1) contained mixtures of alkanes while active extract of Sambucus nigra flower (E341) 
contained a mixture of ursolic acid and oleanolic acid. The LC-MS analysis on Coriandrum sativum seeds (HA6) 
revealed the presence mixture of oxygenated monoterpenes, while another active fraction of C. sativum seeds 
(M338B) showed the presence of carboxylic acid, carboxylate, tetraone, glycerol, carbohydrate and fatty acids. Thus, 
the discovery of potential bioactive compounds from this study could be further investigated as antibiofilm drug 
leads to battle the infections by P. aeruginosa PA14 biofilm in the near future.   
 
Keywords Pseudomonas aeruginosa strain PA14, biofilm, bioassay-guided fractionation, NMR, GC-MS and LC-
MS 
 
 
INTRODUCTION 
 
Tremendous plant extracts have been used in traditional folk medicine and many has been well-
documented for the treatment of certain diseases. Plant natural products have demonstrated a range of 
biological effect including antimicrobial [1] and antibiofilm [2] activity. Many drugs currently on the 
market are either plant natural products or are based on natural product templates. These include morphine 
from opium, quinine from cinchona, artemisinin, salicylic acid, rivastigmine, digitalis glycosides and 
reserpine [3]. Many of the bioactive phytochemicals in such active plant natural products however remain 
to be identified. Plant natural product could provide novel natural antibiofilm agents to fulfill the urgent 
need as therapies for Pseudomonas-related infections. 
 
Pseudomonas aeruginosa is a Gram-negative bacterium and rod shaped with a single polar flagellum. 
P. aeruginosa strain PA14 is a nosocomial pathogen and the primary cause of death in immune-
compromised patients.  P. aeruginosa PA14 can cause various skin infections both localised and diffused, 
and tendency to colonise the surfaces in a biofilm form. P. aeruginosa PA14 is the most prevalent 
infective pathogen and possessed a large number of virulence factors and antimicrobial genes [4]. The 
membrane of P. aeruginosa PA14 acts as a permeability barrier and makes the cells impervious to 
therapeutic concentration such as antibiotics. 
 
The study on the resistance of P. aeruginosa PA14 biofilms has gained a wide interest to explore in-
depth. Plant-derived compounds consist a wide range of pharmacological properties, including 
antioxidant, immunostimulant, anticoagulant, hypocholesterolemic and antimicrobial activity [5], antiviral 
[6] and antibiofilms [7]. Thus, those bioactive compounds with antibiofilm property could be a great 
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choice to inhibit the P. aeruginosa PA14 biofilms and could also provide templates for new antibiofilm 
drug discovery. 
 
Bioassay guided fractionation method can be used to isolate compounds with antibiofilm activity in 
plant extracts. The chemical diversity, chirality and various functional groups present in natural products 
make them an ideal source of new antibiofilm compounds [8]. More than hundreds of plant extracts have 
been investigated for the presence of active compounds against P. aeruginosa PA14 biofilms, however 
only four extracts from three potential plants were chosen to be presented for this paper.  
 
 
EXPERIMENTAL 
 
Plant materials 
The dried plant materials were purchased from a commercial supplier (G. Baldwin and Co., UK) and 
some are supplied by Dr. Xianmin Chang (Orkney College UHI, Kirkwall, UK). All plant materials were 
ground into a fine powder using an analytical mill (IKA A11 BASIC, China). Powdered plant materials 
are packed in a paper envelope and stored in a dry cabinet in the Natural Product Research Laboratories, 
Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, UK.  
 
 
Plant extraction and preparation of samples 
Each plant material (500 g DW) was extracted using n-hexane (1 L), ethyl acetate (1 L) and methanol (1 
L) for 1 h at 25 ºC using a sonicator (DECON F5100b, UK). All extracts were filtered using a qualitative 
filter paper (125mm; Fisher UK) and then concentrated under reduced pressure using a rotary evaporator 
(Buchi R-205, Switzerland) at 40 ºC and later dried under a flow of nitrogen gas.  All extracts were kept 
sealed in glass containers and stored at ± 20 °C. Prior to analysis, each sample was weighed and dissolved 
in dimethyl sulfoxide (DMSO) to obtain a final concentration of 1 mg/mL.  
 
 
Preparation of P. aeruginosa PA14 assay 
The clinical Pseudomonas aeruginosa strain PA14 [9] was obtained from Dr. Nicholas P. Tucker, SIPBS, 
UK. A loop-full of P. aeruginosa PA14 culture from Luria-Bertani (LB) agar was inoculated into 5 mL of 
sterilised LB broth and left in a shaking incubator at 37 °C overnight. Later, 100 µL of overnight culture 
was then inoculated into 50 ml of sterilised LB broth and incubated with shaking at 37°C. The assay was 
prepared by inoculating 25 µL of fresh P. aeruginosa PA14 working culture into 50 ml of M63 medium 
and was slowly shaken to obtain a homogenised assay. 
 
 
Antibacterial activity 
The antibacterial activity of each plant extract against P. aeruginosa PA14 was measured using a disc 
diffusion method. Briefly, 200 µL of fresh P. aeruginosa PA14 cultures were pipetted and spread on 
Mueller-Hinton (MH) agar to produce a uniform P. aeruginosa PA14 lawn.  The P. aeruginosa PA14 
lawn was then embedded with sterilised filter discs (6mm diameter) and 10 µL of each sample (1 mg/mL) 
was pipetted onto each disc and incubated overnight at 37ºC. Gentamicin (1 mg/mL) was used as positive 
control (Control), while DMSO was used as a negative control. The antibacterial activity was shown by 
the presence of clear zones of inhibition surrounding the disc and was measured as diameter (Ø, mm) of 
inhibition zone. 
 
Antibiofilm activity 
The antibiofilm activity of P. aeruginosa PA14 was quantified using high throughput microtitre plate 
method [10]. The analysis was earlier designed in the microplate reader software (Microplate reader 
Spectra Max190, USA). The percentage (%) of biofilm inhibition for P. aeruginosa PA14 was calculated 
as below. 
 
Biofilm inhibiton, BFI (%) =   [1 ± ((T - BE) / Cr)] x 100 
EDUCATUM JSMT Vol. 4 No. 1 (2017) 
ISSN 2289-7070 / eISSN 2462-2451 (1-8) 
 
3 
  
 
 
Where; 
BE: blank (ethanol) 
T:  treatment (P. aeruginosa PA14 assay with sample) 
Ct: treatment control (enriched M63 media with sample)  
Cn: negative control (P. aeruginosa PA14 assay with DMSO)  
Cr: robust control ([(Ct - BE ) + (Cn - BE )]) 
 
 
Isolation and identification of active compounds  
The activity of samples (e.g. plant extracts and subsequently purified compounds) against P. aeruginosa 
PA14 biofilm was isolated using a stepwise separation process called bioassay-guided fractionation 
method. Samples showing more than 50 % biofilm inhibition (BFI) were further investigated for the 
presence of active compounds. Fractionation and isolation for active compounds involved the use of 
chromatographic techniques and detection of the active compounds were identified using NMR, GC-MS 
and LC-MS. 
 
 
RESULTS AND DISCUSSION 
 
Antibacterial activity  
The antibacterial activity of four selected plant extracts (Figure 1) showed that (H338) is the most active 
extract in inhibiting the growth of P. aeruginosa PA14 while (E341) is the least active. The hexane 
(H338) and methanol (M338) extracts of Coriandrum sativum seeds inhibited the growth of P. aeruginosa 
PA14 at the value of 9.7 and 8.0 mm, respectively. Whereas, the ethyl acetate extracts of Ribes nigrum 
leaves (E333) and Sambucus nigra flowers (E341) showed antibacterial activity slightly lower at the value 
of 9.0 and 7.7 mm, respectively.    
 
The C. sativum extracts have shown strong antibacterial activity against P. aeruginosa PA14. 
Compounds such as monoterpene alcohols [11] in C. sativum have shown strong antimicrobial activity 
against Staphylococcus aureus [12] while the essential oil of C. sativum has shown strong activity against 
Campylobacter jejuni [13], Staphylococcus and Eschericia spp. [14]. The plant extracts however showed 
weak antibacterial activity in comparison to gentamicin. A reason for this could be the ability of P. 
aeruginosa PA14 to reverse between motile and sessile states depending on a multitude of physiological 
changes [15]. The physiological changes have been displayed by the swarming motility of P. aeruginosa 
PA14 when tested against certain samples (unpublished data). A weak antibacterial activity was also 
reported on P. fluorescens which displayed the least antibacterial activity against a number of extracts 
from herbs and spices [16].  
 
 
Antibiofilm activity 
The n-hexane (H338) and the methanol extracts (M338) of C. sativum seeds showed a high antibiofilm 
activity at the values of 69.2 and 63.3 % BFI, respectively (Figure 2). C. sativum is well known for its 
antibacterial activity [17]. The only report on antibiofilm activity has been for the essential oil of fresh C. 
sativum against Candida albicans biofilm [18]. To date there has been no study on C. sativum seeds 
against the formation of P. aeruginosa PA14 biofilm. This warranted further investigation on the active 
phytochemicals in C. sativum seeds. Results also revealed that both ethyl acetate extracts of R.  nigrum 
leaves (E333) and S. nigra flowers (E341) possessed antibiofilm activity at the values of 68.3 and 59.2 % 
BFI, respectively (Figure 2). To our knowledge, this is the first report on the antibiofilm activity of R. 
nigrum leaves and S. nigra flowers against the formation of P. aeruginosa PA14 biofilm, hence 
supporting further investigation on their active phytochemicals. 
 
 
 
4                                                                                                Natural Antibiofilm Agents and the Need for Antibiofilm Drug Leads  
 
 
 
 
 
Figure 1 Antibacterial activity of plant extracts against the growth of P. aeruginosa PA14 using a disc diffusion 
assay. Bar charts represent the growth inhibition measured as a diameter (Dia, mm) of clear zone exhibited by each 
sample. Samples coded as H, E and M are referring to n-hexane, ethyl acetate and methanol extracts, respectively. 
Control is gentamicin, a positive control at a concentration of 1 mg/mL. Error bars represent the mean + SD of three 
replicates. 
  
 
 
Figure 2 Antibiofilm activity of plant extracts against P. aeruginosa PA14 biofilm using high throughput microtitre 
plate method. Bar charts represent sample with more than 50 % biofilm inhibition (BFI). Samples coded as H, E and 
M are referring to n-hexane, ethyl acetate and methanol extracts, respectively. Control is gentamicin (1 mg/mL) as a 
positive control. Error bars represent the mean + SD of six replicates. 
 
 
Isolation and identification of active compounds 
 
Figure 3 showed the fractionation of the ethyl acetate extract from Ribes nigrum leaf (E333) against P. 
aeruginosa PA14 biofilm with 68.3 % of biofilm inhibition (BFI). The (E333) was fractionated using 
VLC into eight fractions with the most active fraction, (E333F1) at 54.3% BFI. Later (E333F1) was 
fractionated using Sephadex® column and gave three fractions. (HA30F1S1) at 68.5% BFI was further 
investigated using 1H NMR and then subjected to GC-MS analysis. Four identified compounds were n-
nonadecane, 2-methylnonadecane, 2-methylicosane and 2-methyloctacosane. Further fractionation of 
(HA30F1S1) using silica column gave seven fractions, however none were active (more than 50 % 
biofilm inhibition, BFI). The fractionation process had to be terminated.  
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Figure 3 Fractionation scheme of the ethyl acetate extract from Ribes nigrum leaves 
 
 
 
Figure 4 presented the HRESI-MS analysis of ethyl acetate extract from Sambucus nigra (E341) in 
the negative mode indicated a quasi-molecular ion peak [M-H]- at m/z 455.3531, suggesting a molecular 
ion [M]+ of 456.3603 and corresponding to the molecular formula of C30H48O3 (DBE = 7). This finding 
revealed the presence of ursolic and oleanolic acids (Table 1) which is also the first report on the activity 
of ursolic and oleanolic acids (as a 2:1 mixture) against P. aeruginosa PA14 biofilm.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 HREI-MS spectrum of Sambucus nigra flower extract (E341)  
 
 
Figure 5 shows the fractionation scheme obtained for the hexane (H338) and methanol (M338) 
extracts of C. sativum seeds. The separation of phytochemicals was done using bioassay-guided 
fractionation and isolation methods which are tested against the growth of P. aeruginosa PA14 biofilm. 
Fraction (H338F3) afforded from fractionation of (H338) showed high antibiofilm activity (57.6 % BFI). 
Further fractionation of (H338F3) had produced (H338F3S10) and (H338F3S12) which showed strong 
antibiofilm activity at 60.8 and 67.9 % BFI, respectively. Fractionation of (H338F3S10) afforded (HA6) 
detected with strong antibiofilm activity at 62.5 % BFI, while (H338F3S12) failed to produce any active 
fraction with more than 50 % inhibition against P. aeruginosa PA14 biofilm. The methanol extract 
[2M-H]- 
[M-H]- 
6                                                                                                Natural Antibiofilm Agents and the Need for Antibiofilm Drug Leads  
 
 
 
(M338) was partitioned into DCM (M338D), n-butanol (M338B) and water (M338W) extracts. 
Antibiofilm screening showed that all extracts exhibited strong antibiofilm activity. The most active 
extract was (M338D) with 65.4 % BFI followed by (M338W) and (M338B) at 62.1 and 53.4 % BFI, 
respectively.   
 
(HA6) was further analysed to detect and identify the active compounds. Both spectra and assignment 
of 1H and 13C NMR data for (HA6) are presented in Table 1. Later (HA6) was subjected to LC-MS 
analysis in the positive and negative ESI mode and traces of compounds were identified using MZmine 
software. Possible metabolites identified in the ESI positive mode (Table 2) include 10-undecenal, 
linalool oxide (pyranoid and furanoid), 4-ethylcamphor, dodecanal, 2-hexylfuran and caryophyllene 
oxide. Possible metabolites identified in the ESI negative ionisation mode of (HA6) include 12(13)-
EpOME and (E)-12,13-dihydroxy-11-methoxyoctadec- 9-enoic acid (Table 3). To our knowledge, this is 
the first report of those compounds with antibiofilm activity against P. aeruginosa PA14.    
 
 
 
Figure 5 Fractionation scheme of the hexane (H) ad methanol (M) extracts of Coriandrum sativum seeds (338) 
 
 
Table 1 1H and 13C NMR peak assignments for (HA6) 
 
įH (J Hz)  Proton 
types 
 
įC (J Hz)  Carbon types  
0.86  - CH3  15.51  
1.26 - (CH2)n  24.79 RCH2- 
1.89  - CH2-  25.17  
2.02..2.04  - CH3  31.82  
2.11..2.20  - CH2- 
 
34.12 -CH2- 
2.68..2.69  - OH 
 
181.95 C=O 
3.32..3.35  - CH2-    
3.34 - CHOH 
   
4.26..4.28 - CH- 
   
5.48  - CH=CH - 
   
8.52..8.54  Ar-H 
   
All spectra were recorded in CD32'ZLWKįH DWSSPDQGįC at 49.00 ppm 
 
 
 
 
 
 
 
 
 
Coriandrum 
sativum seed 
H338 
(69.2 %) 
M338 
(63.3 %) 
H338F3 
(57.6 %) 
H338F3S10 
(60.8 %) 
H338F3S12 
(67.9 %) 
HA2 
(51.7 %) 
HA3  
(52.2 %) 
HA6 
(62.5 %) NSF 
M338B  
(53.4 %) 
M338D 
(65.4 %) 
M338W 
(62.1 %) 
M338DF1 
(51.6 %) 
NMR & LC-MS 
analyses 
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Table 2 Compounds identified in (HA6) using positive mode ESI-MS 
 
Compound Formula Calculated 
mass 
Theoretical 
mass 
Mass 
difference 
Error 
(ppm) 
2-hexylfuran (C22) C10H16O 152.1200851 152.1201152 -0.0000301 -0.1981329 
Linalool oxide (C2) C10H18O2 170.1306442 170.1306799 -0.0000357 -0.2099563 
Linalool oxide (C23) C10H18O2 170.1307357 170.1306799 0.0000558 0.3278656 
10-undecenal (C24) C11H2OO 168.1514114 168.1514154 -0.0000040 -0.0237881 
4-Ethylcamphor (C25) C12H20O 180.1513809 180.1514154 -0.0000345 -0.1915056 
Dodecenal (C26) C12H24O 184.1827072 184.1827156 -0.0000084 -0.0453897 
Caryophyllene oxide (C27) C15H24O 220.1826919 220.1827156 -0.0000237 -0.1074562 
 
Table 3 Compounds identified in (HA6) using negative mode ESI-MS 
 
Compound Formula Calculated 
mass 
Theoretical 
mass 
Mass 
difference 
Error 
(ppm) 
12(13)-EpOME (C28) C18H32O3 296.2351395 296.2351438 -0.0000043 -0.0145254 
(E)-12,13-dihydroxy-11-
methoxyoctadec- 9-enoic acid 
(C29) 
C19H36O5 344.2562729 344.2562730 -0.0000001 -0.0002326 
 
 
CONCLUSION 
 
The effect of plant extracts in destabilising and inhibiting biofilms is a promising approach for the 
discovery of new antibiofilm hits and drug leads. This study led to the identification of potential bioactive 
compounds from the selected plant as natural antibiofilm agents against P. aeruginosa PA14. The 
compounds were mixture of alkanes from Ribes nigrum leaf, mixture of ursolic acid and oleanolic acid 
from Sambucus nigra flowers and mixture of oxygenated monoterpenes, carboxylic acid, carboxylate, 
tetraone, glycerol, carbohydrates and fatty acids from Coriandrum sativum seeds. More in-depth study 
therefore could investigate the mechanism beneath the inhibition of P. aeruginosa PA14 biofilm using 
these compounds in the near future. Notably more researches needed to be done before the compounds 
can be considered as potent antibiofilm agents. Thus, in future studies, antibiofilm activity of those 
compounds against positive control (gentamicin) and other pure natural products either alone or in mixed-
ratios will be investigated. Others, such as activity of those compounds against other biofilms of other 
Pseudomonas strains also tend to be evaluated. Results discovered from these findings therefore will be 
presented and discussed separately in the next publications.  
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